Clinical trial
Impact of Flaxseed Lignan (Brevail) on Polycystic Ovarian Syndrome
NCT01396369 is registered in ClinicalTrials.gov with University of Kansas Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Flaxseed Lignan (Brevail) on Polycystic Ovarian Syndrome
- Lead sponsor
- University of Kansas Medical Center
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- June 30, 2011
- Completion date
- December 31, 2013
- Enrollment
- 9 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
polycystic ovarian syndrome